ViewRay
NASDAQ: VRAY
Developing MRI-guided radiation therapy systems for cancer treatment.
F-Prime Team
Sector
Life SciencesCategory
MedtechLocation
Oakwood Village, OHInitial Investment
2008
Developing MRI-guided radiation therapy systems for cancer treatment.
ViewRay (NASDAQ: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. Which uses a high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology.